Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.38% for IHE. HRTS is down -4.67% year-to-date (YTD) with -$713K in YTD flows. IHE performs better with 2.1% YTD performance, and +$129M in YTD flows. Run a side-by-side ETF comparison of HRTS and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HRTS IHE | -5.84%-4.25% | -4.63%+1.32% | -4.67%+2.10% | +15.66%+27.98% | n/a+59.87% | n/a+56.57% |
| Flows | HRTS IHE | -$2M+$5M | +$712K+$142M | -$713K+$129M | -$17M+$248M | -+$359M | -+$393M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HRTS IHE | +14.54%+16.09% | +17.68%+20.46% | n/a+15.96% | n/a+15.82% |
| Max drawdown | HRTS IHE | -7.89%-5.75% | -13.50%-14.18% | n/a-16.04% | n/a-16.12% |
| Max drawdown duration | HRTS IHE | 65d12d | 163d150d | n/a210d | n/a669d |
HRTS | IHE | |
Last sale 3/13/2026 at 1:30 PM | $33.67 | $86.56 |
| Previous close 03/12/2026 | $33.85 | $86.66 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HRTS | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HRTS | IHE | |
|---|---|---|
| Last price | $33.67 | $86.56 |
| 1D performance | -0.54% | -0.12% |
| AuM | $51.53 M | $995.33 M |
| E/R | 0.99% | 0.38% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.